(1 - 19 von 27
)
Collaboration has triggered biologics prowess in the northeast |...
www.thetimes.co.uk
· Dr Caroline Barelle has scooped a string of prizes since setting up Elasmogen in The Sunday Times. Sunday March , am GMT, ...
Elasmogen gibt Patentschutz für 2 neue VNAR- und soloMER ...www.ots.at › presseaussendung › OTS_ _OTS0169 › elasmogen-...
www.ots.at
· Caroline Barelle, CEO von Elasmogen, sagte: "Wir freuen uns, dass all unsere harte Arbeit und unser Erfindergeist mit der Erteilung neuer ...
caroline barelle - Opera News Ghanagh.opera.news › tags › caroline-barelle
gh.opera.news
All the caroline barelle news, pictures and more, Want to know the latest updates about caroline barelle? — Click here to gh.opera.news.
OBN Awards Winners Recognised at Industry Leading Event
www.finanznachrichten.de
Caroline Barelle - CFO - Elasmogen. Anton Hutter - Partner & Patent Attorney - Venner Shipley. Carolyn Porter - Deputy Head of Technology Transfer - OUI. About OBN-www.obn.org.uk.
Almac Discovery, Elasmogen and Innovate UK collaborate
www.manufacturingchemist.com
... lives of so many people, there is a continual need to bring new innovative therapies into the clinic” said Caroline Barelle, CEO, Elasmogen.
Converge Challenge now open for applications | Physics Scotland
www.supa.ac.uk
Caroline Barelle, Elasmogen, Converge Challenge Second Prize – University of Aberdeen. “During this journey and I have met some incredible people and thanks to the continual support, expert advice and training that has equipped me with confidence, the know-how and a “CAN DO” attitude to make things happen.
BioTrinity Attendence Continues to Rise Labmate Online
www.labmate-online.com
OBN, a membership organisation supporting the UK’s innovative life sciences companies, announced that its annual BioTrinity event again proved to be a...
Spring Phcl Seminar Series - 10:00 AM - Shideman-Sterling Award ...med.umn.edu › news-events › spring-phcl-seminar-s...
med.umn.edu
Caroline Barelle, PhD. CEO Elasmogen Ltd. Barelle Photo. Caroline is CEO and co-founder of Elasmogen, a company that discovers and develops soloMER ...
Pioneering drug discovery gets major funding to move to next stage
www.scottish-enterprise-mediacentre.com
Scottish Enterprise Newsroom
Your Latest Ophthalmology News for SMi's Ophthalmic Drugs
www.thefreelibrary.com
Free Online Library: Your Latest Ophthalmology News for SMi's Ophthalmic Drugs by
Results Base - Nicol of Skene Westhill 10K 2017
www.resultsbase.net
Results Base are the leading timing company in the UK providing solutions for over 500 events a year
LIVE Keynote panel discussion: Bispecific discovery and emerging...
app.swapcard.com
Moderator: Caroline Barelle, CEO & Co-Founder, Elasmogen
Paul Carter, Genentech Fellow, Antibody Engineering, Genentech
John Delaney, Director, Research...
Elasmogen And Almac Discovery Join Forces To Tackle Solid Tumors |...
www.contractpharma.com
Firms will co-develop Elasmogen's soloMER technology
Elasmogen resumes Covid and cancer projects thanks to £374,000 of...
www.insider.co.uk
Aberdeen life sciences firm backed by UK and Scottish Government funding
Shark protein cancer drug pioneer secures £2 million investment -...
www.insider.co.uk
Aberdeen-based Elasmogen wins new backing from Deepbridge Capital to develop '10 times as effective' treatments
Royal Society announces Entrepreneur in Residence scheme ...royalsociety.org › news › › entrepreneur-in...
royalsociety.org
· Dr Caroline Barelle, Elasmogen, Queen's University Belfast · Mr Phil Bates, University of Bristol · Mrs Dawn Bonfield, Towards Vision, King's ...
Your Latest Ophthalmology News for SMi’s Ophthalmic Drugs
www.pharmajournalist.com
ELASMOGEN: Dr Caroline Barelle named “Rising Stars: Extraordinary Talent”. The CEO of Elasmogen, Dr Caroline Barelle was named as the ...
Scottish women lead way for UK's high-growth firms | The Scotsmanwww.scotsman.com › business › scottish-women-lead-way-for-uks-high-gr...
www.scotsman.com
· Aberdeen life sciences entrepreneur Caroline Barelle heads one of the female-powered businesses featured in the report.
VNAR Based Oncology Platform in development - Almacwww.almacgroup.com › News Items
www.almacgroup.com
· ... there is a continual need to bring new innovative therapies into the clinic” said Caroline Barelle, Chief Executive Officer, Elasmogen.
sortiert nach Relevanz / Datum